AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Keros Therapeutics, Inc.

$11.04 -$7.50 (-40.45%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$11.36
Day Range
$10.99$11.49
Year Range
$9.69$22.55
Market Cap
218.89M
AVG Volume
211.87K
Trailing/Forward PE
-2.98/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KROS Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q215.01M
26 Q133.18M
25 Q4244.06M
25 Q3246.72M
25 Q2232.84M
25 Q1214.71M
24 Q43.55M
24 Q3651K
24 Q2271K
24 Q1234K
Net Income (USD) · TTM
-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KROS Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-83.16M
26 Q1-85.14M
25 Q487.01M
25 Q364.45M
25 Q218.77M
25 Q14.21M
24 Q4-187.35M
24 Q3-181.57M
24 Q2-168.05M
24 Q1-160.3M
Operating Income (USD) · TTM
-300M-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KROS Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-101.47M
26 Q1-110.35M
25 Q467.57M
25 Q343.59M
25 Q2312K
25 Q1-10.31M
24 Q4-210.83M
24 Q3-204.03M
24 Q2-188.66M
24 Q1-179.56M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: KROS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.

Keros Therapeutics, Inc.
KROS
Stockpicker

Video analysis: KROS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KROS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.